of related brassicaceous species. There is no research on biodiversity because what we are actually looking at is quite controlled in the sense that we are trying to keep away any genetically compatible plants in the context of the limit and control trials. Senator CHERRY ?Do you think there should be research on biodiversity as part of an approval process? Dr Meek ?I think the issue is that we have to look at risk to human health and safety in the environment. Biodiversity is one area which we look at closely in the context of, for example, insecticidal GM crops but, again, there is an issue there, a close interaction between us and the APVMA, and in that context things like insect resistant management strategies which are to do with preserving the reproductive capacity of the insects that are impacted upon in the context of those GMOs are something that is run through the APVMA.